IP Verse

Lyophilized Liposomes - EP2768484B1

PatentPatent Analysis

EP2768484

CELATOR PHARMACEUTICALS
Application Number
EP12841616A
Filing Date
Oct 15, 2012
Status
Revoked
Apr 27, 2024
Grant Date
Jul 24, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3300601B1
EP2120568B1

Bibliography

The patent EP2768484B1 was granted to Celator Pharmaceuticals on Jul 24, 2019 following the initial filing on Oct 15, 2012 under the application number EP12841616A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

D YOUNGApr 24, 2020ADMISSIBLE
SANDOZApr 23, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents